Literature DB >> 19917249

The homeodomain protein HOXB13 regulates the cellular response to androgens.

John D Norris1, Ching-Yi Chang, Bryan M Wittmann, Rebecca S Kunder, Huaxia Cui, Daju Fan, James D Joseph, Donald P McDonnell.   

Abstract

HOXB13 is a member of the homeodomain family of sequence-specific transcription factors and, together with the androgen receptor (AR), plays a critical role in the normal development of the prostate gland. We demonstrate here that, in prostate cancer cells, HOXB13 is a key determinant of the response to androgens. Specifically, it was determined that HOXB13 interacts with the DNA-binding domain of AR and inhibits the transcription of genes that contain an androgen-response element (ARE). In contrast, the AR:HOXB13 complex confers androgen responsiveness to promoters that contain a specific HOXB13-response element. Further, HOXB13 and AR synergize to enhance the transcription of genes that contain a HOX element juxtaposed to an ARE. The profound effects of HOXB13 knockdown on androgen-regulated proliferation, migration, and lipogenesis in prostate cancer cells highlight the importance of the observed changes in gene expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19917249      PMCID: PMC2788777          DOI: 10.1016/j.molcel.2009.10.020

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  31 in total

1.  An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter.

Authors:  K B Cleutjens; H A van der Korput; C C van Eekelen; H C van Rooij; P W Faber; J Trapman
Journal:  Mol Endocrinol       Date:  1997-02

2.  Synergistic coactivator function by coactivator-associated arginine methyltransferase (CARM) 1 and beta-catenin with two different classes of DNA-binding transcriptional activators.

Authors:  Stephen S Koh; Hongwei Li; Young-Ho Lee; Randall B Widelitz; Cheng-Ming Chuong; Michael R Stallcup
Journal:  J Biol Chem       Date:  2002-04-30       Impact factor: 5.157

3.  The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1.

Authors:  C L Bevan; S Hoare; F Claessens; D M Heery; M G Parker
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

4.  Hoxb-13: a new Hox gene in a distant region of the HOXB cluster maintains colinearity.

Authors:  L Zeltser; C Desplan; N Heintz
Journal:  Development       Date:  1996-08       Impact factor: 6.868

5.  Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells.

Authors:  S Yeh; C Chang
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

6.  Androgens markedly stimulate the accumulation of neutral lipids in the human prostatic adenocarcinoma cell line LNCaP.

Authors:  J V Swinnen; P P Van Veldhoven; M Esquenet; W Heyns; G Verhoeven
Journal:  Endocrinology       Date:  1996-10       Impact factor: 4.736

7.  Differential presentation of protein interaction surfaces on the androgen receptor defines the pharmacological actions of bound ligands.

Authors:  John David Norris; James David Joseph; Andrea Barreto Sherk; Dalia Juzumiene; Philip Stewart Turnbull; Stephen William Rafferty; Huaxia Cui; Erin Anderson; Daju Fan; Delita Arnelle Dye; Xiang Deng; Dmitri Kazmin; Ching-Yi Chang; Timothy Mark Willson; Donald Patrick McDonnell
Journal:  Chem Biol       Date:  2009-04-24

8.  Hox proteins functionally cooperate with the GC box-binding protein system through distinct domains.

Authors:  Mitsuko Suzuki; Naoto Ueno; Atsushi Kuroiwa
Journal:  J Biol Chem       Date:  2003-05-27       Impact factor: 5.157

9.  Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation.

Authors:  T Ikonen; J J Palvimo; P J Kallio; P Reinikainen; O A Jänne
Journal:  Endocrinology       Date:  1994-10       Impact factor: 4.736

10.  A coregulatory role for the TRAP-mediator complex in androgen receptor-mediated gene expression.

Authors:  Qianben Wang; Dipali Sharma; Yunsheng Ren; Joseph D Fondell
Journal:  J Biol Chem       Date:  2002-09-05       Impact factor: 5.157

View more
  104 in total

1.  The stress response mediator ATF3 represses androgen signaling by binding the androgen receptor.

Authors:  Hongbo Wang; Ming Jiang; Hongmei Cui; Mengqian Chen; Ralph Buttyan; Simon W Hayward; Tsonwin Hai; Zhengxin Wang; Chunhong Yan
Journal:  Mol Cell Biol       Date:  2012-06-04       Impact factor: 4.272

2.  The metabolic regulator ERRα, a downstream target of HER2/IGF-1R, as a therapeutic target in breast cancer.

Authors:  Ching-yi Chang; Dmitri Kazmin; Jeff S Jasper; Rebecca Kunder; William J Zuercher; Donald P McDonnell
Journal:  Cancer Cell       Date:  2011-10-18       Impact factor: 31.743

3.  Histone methyltransferase NSD2/MMSET mediates constitutive NF-κB signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop.

Authors:  Ping Yang; Linlang Guo; Zhijian J Duan; Clifford G Tepper; Ling Xue; Xinbin Chen; Hsing-Jien Kung; Allen C Gao; June X Zou; Hong-Wu Chen
Journal:  Mol Cell Biol       Date:  2012-05-29       Impact factor: 4.272

Review 4.  Moving Beyond the Androgen Receptor (AR): Targeting AR-Interacting Proteins to Treat Prostate Cancer.

Authors:  Christopher Foley; Nicholas Mitsiades
Journal:  Horm Cancer       Date:  2016-01-04       Impact factor: 3.869

5.  Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for prostate biopsy.

Authors:  Florian R Schroeck; Kimberly A Zuhlke; Javed Siddiqui; Rabia Siddiqui; Kathleen A Cooney; John T Wei
Journal:  J Urol       Date:  2012-10-02       Impact factor: 7.450

6.  ZFX Mediates Non-canonical Oncogenic Functions of the Androgen Receptor Splice Variant 7 in Castrate-Resistant Prostate Cancer.

Authors:  Ling Cai; Yi-Hsuan Tsai; Ping Wang; Jun Wang; Dongxu Li; Huitao Fan; Yilin Zhao; Rohan Bareja; Rui Lu; Elizabeth M Wilson; Andrea Sboner; Young E Whang; Deyou Zheng; Joel S Parker; H Shelton Earp; Gang Greg Wang
Journal:  Mol Cell       Date:  2018-09-27       Impact factor: 17.970

Review 7.  Rationale for the development of alternative forms of androgen deprivation therapy.

Authors:  Sangeeta Kumari; Dhirodatta Senapati; Hannelore V Heemers
Journal:  Endocr Relat Cancer       Date:  2017-05-31       Impact factor: 5.678

8.  The ETS domain transcription factor ELK1 directs a critical component of growth signaling by the androgen receptor in prostate cancer cells.

Authors:  Mugdha Patki; Venkatesh Chari; Suneethi Sivakumaran; Mesfin Gonit; Robert Trumbly; Manohar Ratnam
Journal:  J Biol Chem       Date:  2013-02-20       Impact factor: 5.157

9.  Gene regulatory mechanisms underpinning prostate cancer susceptibility.

Authors:  Thomas Whitington; Ping Gao; Wei Song; Helen Ross-Adams; Alastair D Lamb; Yuehong Yang; Ilaria Svezia; Daniel Klevebring; Ian G Mills; Robert Karlsson; Silvia Halim; Mark J Dunning; Lars Egevad; Anne Y Warren; David E Neal; Henrik Grönberg; Johan Lindberg; Gong-Hong Wei; Fredrik Wiklund
Journal:  Nat Genet       Date:  2016-03-07       Impact factor: 38.330

Review 10.  Shaping Chromatin States in Prostate Cancer by Pioneer Transcription Factors.

Authors:  William Hankey; Zhong Chen; Qianben Wang
Journal:  Cancer Res       Date:  2020-02-24       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.